Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has acquired drug development consultancy Great Lakes Drug Development (GLDD), based in Brighton, Mich. Both companies focus on pharmacokinetic (PK) and pharmacodynamic (PD) analysis, project management and pharmacometric modeling and simulation. GLDD focuses on early development work, while Certara’s products and services span the entire drug development continuum.

“This acquisition will enable us to leverage the significant synergies between Certara’s and GLDD’s business focus, experience and culture, while expanding our customer base,” said Daniel Weiner, Ph.D., senior vice president and general manager at Certara. 

The GLDD office in Michigan will become the sixth in Certara’s worldwide consultancy operations, located in Sunnyvale, Calif.; Cary, N.C.; Montreal; Tokyo; and England.